Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 5;9(6):750.
doi: 10.3390/foods9060750.

Whey for Sarcopenia; Can Whey Peptides, Hydrolysates or Proteins Play a Beneficial Role?

Sarah Gilmartin  1   2 , Nora O'Brien  2 , Linda Giblin  1
Affiliations
Free PMC article
Review

Whey for Sarcopenia; Can Whey Peptides, Hydrolysates or Proteins Play a Beneficial Role?

Sarah Gilmartin et al. Foods. .
Free PMC article

Abstract

As the human body ages, skeletal muscle loses its mass and strength. It is estimated that in 10% of individuals over the age of 60, this muscle frailty has progressed to sarcopenia. Biomarkers of sarcopenia include increases in inflammatory markers and oxidative stress markers and decreases in muscle anabolic markers. Whey is a high-quality, easily digested dairy protein which is widely used in the sports industry. This review explores the evidence that whey protein, hydrolysates or peptides may have beneficial effects on sarcopenic biomarkers in myoblast cell lines, in aged rodents and in human dietary intervention trials with the older consumer. A daily dietary supplementation of 35 g of whey is likely to improve sarcopenic biomarkers in frail or sarcopenia individuals. Whey supplementation, consumed by an older, healthy adult certainly improves muscle mTOR signaling, but exercise appears to have the greatest benefit to older muscle. In vitro cellular assays are central for bioactive and bioavailable peptide identification and to determine their mechanism of action on ageing muscle.

Keywords: C2C12; aged animals; exercise; muscle; older adult; sarcopenia; whey protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tieland M., Trouwborst I., Clark B.C. Skeletal muscle performance and ageing. J. Cachexiasarcopenia Muscle. 2018;9:3–19. doi: 10.1002/jcsm.12238. - DOI - PMC - PubMed
    1. Aagaard P., Suetta C., Caserotti P., Magnusson S.P., Kjaer M. Role of the nervous system in sarcopenia and muscle atrophy with aging: Strength training as a countermeasure. Scand. J. Med. Sci. Sports. 2010;20:49–64. doi: 10.1111/j.1600-0838.2009.01084.x. - DOI - PubMed
    1. Kalyani R.R., Corriere M., Ferrucci L. Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2:819–829. doi: 10.1016/S2213-8587(14)70034-8. - DOI - PMC - PubMed
    1. Patel H.P., Syddall H.E., Jameson K., Robinson S., Denison H., Roberts H.C., Edwards M., Dennison E., Cooper C., Aihie Sayer A. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: Findings from the Hertfordshire Cohort Study (HCS) Age Ageing. 2013;42:378–384. doi: 10.1093/ageing/afs197. - DOI - PMC - PubMed
    1. MacEwan J.P., Gill T.M., Johnson K., Doctor J., Sullivan J., Shim J., Goldman D.P. Measuring Sarcopenia Severity in Older Adults and the Value of Effective Interventions. J. Nutr. Health Aging. 2018;22:1253–1258. doi: 10.1007/s12603-018-1104-7. - DOI - PMC - PubMed